P1.01-38 A Phase II With a Lead-In Phase I Study to Examine Safety and Efficacy of Hydroxychloroquine and Gefitinib in Advanced NSCLC
Huang Y, Wong A, Soo R, Soh T, Pang A, Tan C, Ling W, Voon P, Lim J, Sundar R, Kumarakulasinghe N, Lim H, Goh B, Chin T. P1.01-38 A Phase II With a Lead-In Phase I Study to Examine Safety and Efficacy of Hydroxychloroquine and Gefitinib in Advanced NSCLC. Journal Of Thoracic Oncology 2018, 13: s474-s475. DOI: 10.1016/j.jtho.2018.08.594.Peer-Reviewed Original Research